Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-02-17 AGM Information
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Result of General Meeting & working capital update
AGM Information Classification · 1% confidence The document begins with an 'RNS Number' and is dated, indicating a regulatory announcement. The title explicitly states 'Result of General Meeting and working capital update'. The content details the outcome of a General Meeting (shareholder vote) where a resolution failed, impacting capital reorganization and the ability to issue new shares. This directly relates to shareholder voting results and capital structure changes. While it mentions the result of a General Meeting (DVA), the primary focus is the immediate consequence on the company's ability to raise capital and its working capital position, which is a significant corporate event announcement. Since the document reports the outcome of a shareholder vote (General Meeting result) and discusses the subsequent impact on capital raising abilities, it strongly aligns with Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a full report (10-K, IR), a presentation (IP), or a simple dividend notice (DIV). Given the explicit mention of the 'Result of General Meeting', DVA is the most precise fit.
2020-02-17 English
Change of Venue for General Meeting-17 Feb 2020
Regulatory Filings Classification · 1% confidence The document is a formal announcement disseminated via 'RNS Number' (Regulatory News Service), which is a primary channel for UK listed companies. The content explicitly discusses a 'CHANGE OF VENUE FOR GENERAL MEETING'. A General Meeting (GM) is a shareholder meeting. The document is short and focuses on an administrative change (venue change due to flooding) for an upcoming meeting, rather than the results of the vote (DVA) or the proxy materials themselves (DEF 14A/PSI). Since it is a regulatory announcement concerning a shareholder meeting logistics, and it is distributed via RNS, it fits best under the general Regulatory Filings category (RNS) as it is not a specific AGM presentation (AGM-R) or a proxy statement (PSI). However, given the specific nature of the announcement relating directly to a General Meeting, and the fact that RNS is the distribution mechanism, RNS is the most appropriate general classification for this type of immediate regulatory update that doesn't fit a more specific operational category.
2020-02-12 English
Posting of Circular & Notice of General Meeting
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 4742B') dated January 30, 2020. The core subject is the 'Posting of Circular and Notice of General Meeting' concerning a 'proposed capital reorganisation' (Consolidation and Sub-Division of shares) and seeking authority to allot shares. This directly relates to changes in the company's capital structure and financing authority, which aligns with the 'Capital/Financing Update' definition (CAP). Although it mentions a General Meeting, the primary focus is the capital action itself, not the voting results (DVA) or the full AGM materials (AGM-R). Since it details the mechanics of a share consolidation/sub-division and seeks authority for future share allotment, CAP is the most precise fit, although it also contains elements of a notice for a meeting (which would typically be covered by PSI or AGM-R if it were a proxy statement). Given the explicit focus on the mechanics of the capital reorganisation, CAP is selected over the meeting notice aspect.
2020-01-30 English
Update - ValiSeek
M&A Activity Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content details a strategic update regarding a joint venture (ValiSeek), a new special purpose vehicle (Black Cat Bio Limited), and a Letter of Intent (LOI) concerning the commercialization and funding of a therapeutic drug (VAL401). This type of corporate action, strategic partnership, and funding update, disseminated via RNS, is a general regulatory announcement. Since it does not fit the specific criteria for M&A (TAR), Capital Change (CAP/SHA), Director's Dealing (DIRS), or Earnings Release (ER), the most appropriate classification is the general regulatory filing category, RNS.
2020-01-14 English
Placing, Issue of Warrant & Appointment of Broker
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 06 January 2020. The content details a 'Placing, Issue of Warrant & Appointment of Broker,' announcing the raising of £200,000 through new share issues and the appointment of a joint broker. This type of announcement, which details financing activities (share issue/placing) and corporate appointments, is typically disseminated via regulatory news services. The document explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' While it contains elements of Capital/Financing Update (CAP) and Share Issue (SHA), the primary function and format align with a general regulatory announcement disseminated through the RNS system, especially since it is not a full financial report (like 10-K or IR) or a specific proxy/insider trade filing. Given the explicit RNS header and the nature of the announcement (fundraising and broker appointment), the most appropriate general classification is Regulatory Filings (RNS), which serves as the catch-all for such market notices.
2020-01-06 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1495 characters) and contains the header 'RNS Number : 9699W'. It describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a routine, immediate announcement concerning market operations rather than a comprehensive financial report (like 10-K or IR) or a specific corporate action like a dividend or management change. Since it is a general regulatory announcement distributed via the RNS service and does not fit into the more specific categories (like DIV, MANG, ER), the most appropriate classification is the general Regulatory Filings fallback category.
2019-12-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.